Update 27 January, 2023: In January 2023, lecanemab was granted accelerated approval by the FDA and made available to patients under the brand name…
Mild cognitive impairment (MCI), the condition associated with early stages of Alzheimer’s disease and related forms of dementia (like vascular dementia or Lewy Body…
Can a virus lead to Alzheimer’s disease? Alzheimer’s expert Ruth Itzhaki at the University of Oxford reflects on a career dedicated to one of…
They’ve been studying the same group of people for 76 years. This is what they’ve learned about Alzheimer’s disease… so far. Psychology in epidemiology…
Most Alzheimer’s treatments on the market today help manage symptoms, like memory loss — but they don’t get at the root cause. Roche hoped their…
Lapses in memory are a fairly normal part of healthy aging. But in the early stages of neurodegenerative diseases like Alzheimer’s dementia, cognitive changes…
Research shows two of every five cases of Alzheimer’s and related dementias are preventable. According to credible, peer-reviewed scientific studies, here are the 8…
Researchers in Tokyo continue encouraging research on oxytocin as a potential Alzheimer’s drug target. When administered nasally, the hormone appeared to reverse cognitive decline…
Donald Weaver, a researcher and physician who acts as co-director at the Krembil Brain Institute, provides evidence that Alzheimer’s is a result of the…
Ever since German physician Alois Alzheimer first described the disease in 1906, scientists have searched for the root cause of Alzheimer’s. Though the most…
The gold-standard methods for diagnosing Alzheimer’s disease are lumbar punctures and PET brain scans. But these methods can be uncomfortable — not to mention…
Healthy diets seem to neurodegenerative diseases like Alzheimer’s. But new research calls everything we thought we knew about the Mediterranean diet into question. Why…
While scientists don’t know yet what causes Alzheimer’s, beta-amyloid protein plaques remain one of the prime suspects. While many approaches have focused on clearing…
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…
Here’s a theory: Alzheimer’s biomarker beta-amyloid could — rather than killing the brain — actually be trying to defend it. The provocative idea builds on…